Abstract P060 – Table 1. Baseline demographic and clinical characteristics of the 416 PLWHIV starting BIC/FTC/TAF in the Icona cohort.
	ART‐naive (N=416)
Italian, n (%)	239	(70.43)
Ethnicity, Caucasian, n (%)	329	(79.1)
Gender, female, n (%)	73	(17.5)
Year of BIC start, median (IQR)	2020	(2020‐2021)
Year ART start, median (IQR)	2020	(2020‐2021)
Age, years, median (IQR)	42	(32‐52)
>50 years, n (%)	124	(29.81)
Mode of HIV transmission, n (%)
Heterosexual	172	(41.35)
IVDU	19	(4.57)
MSM	188	(45.19)
Other/Unknown	37	(8.89)
HCVAb positive status, n (%)	20	(4.81)
HBsAg positive status, n (%)	11	(2.64)
AIDS, n (%)	59	(14.2)
CD4, cells/mmc, median (IQR)	280	(87‐495)
CD4<200 cells/mmc, n (%)	165	(39.7)
CD4<350 cells/mmc, n (%)	241	(57.9)
CD4/CD8 ratio, median (IQR)	0.33	(0.14‐0.58)
HIV‐RNA, log10 copies/mL, median (IQR)	5.02	(4.39‐5.60)
LDL cholesterol, mg/dL, median (IQR)	102	(80‐124)
HDL cholesterol, mg/dL, median (IQR)	40	(33‐49)
Triglycerides, mg/dL, median (IQR)	94	(71‐139)
Serum glucose, mg/dL, median (IQR)	87	(80‐93)
eGFR, CKD‐EPI, ml/min, median (IQR)	106.4	(92.2‐117.5)
Weight, kg, median (IQR)	70	(60‐78)
BMI, kg/m2, median (IQR)	23	(20.6‐24.7)
Follow‐up on BIC, years, median (IQR)	0.83	(0.44‐1.22)